Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Federal Trade Commission
Fuji
Harvard Business School
UBS
Teva
Boehringer Ingelheim
Baxter
US Army
US Department of Justice

Generated: February 19, 2018

DrugPatentWatch Database Preview

WYTENSIN Drug Profile

« Back to Dashboard

Which patents cover Wytensin, and what generic alternatives are available?

Wytensin is a drug marketed by Wyeth Ayerst and is included in one NDA.

The generic ingredient in WYTENSIN is guanabenz acetate. There are six drug master file entries for this compound. Additional details are available on the guanabenz acetate profile page.
Drug patent expirations by year for WYTENSIN
Medical Subject Heading (MeSH) Categories for WYTENSIN

US Patents and Regulatory Information for WYTENSIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-001 Sep 7, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-002 Sep 7, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-003 Sep 7, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for WYTENSIN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-001 Sep 7, 1982 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-002 Sep 7, 1982 ➤ Sign Up ➤ Sign Up
Wyeth Ayerst WYTENSIN guanabenz acetate TABLET;ORAL 018587-003 Sep 7, 1982 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
US Department of Justice
Argus Health
Merck
Harvard Business School
McKinsey
Johnson and Johnson
Medtronic
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot